AGBA Acquisition (AGBAW) has had the highest return since January 1, 2024 by a US stock, returning 4,488.5%.
ASSET | % RETURN |
---|---|
AGBA Acquisition (AGBAW) | 4,488.52% |
Nexalin Technology (NXLIW) | 1,829.58% |
Spectaire (SPECW) | 1,150% |
Palladyne AI (PDYNW) | 999% |
error (ZVZZT) | 804.57% |
LENZ Therapeutics (LENZ) | 802.61% |
AdTheorent (ADTHW) | 773.74% |
Binah Capital Group, Inc Warrants (BCGWW) | 760.87% |
Codere Online Luxembourg SA Warrants (CDROW) | 759.97% |
NorthView Acquisition Corporation Warrant (NVACW) | 700% |
Breeze Holdings Acquisition (BREZW) | 669.23% |
GeneDx (WGS) | 628.15% |
Inception Growth Acquisition Limited Warrants (IGTAW) | 606.58% |
AGBA Acquisition (AGBA) | 605.63% |
Swvl (SWVL) | 605.63% |
Janone (JAN) | 602.7% |
Armada Acquisition Corp I Warrant (AACIW) | 600% |
Elevation Oncology (ELEV) | 585.19% |
Society Pass (SOPA) | 548.21% |
Corbus Pharmaceuticals (CRBP) | 545.09% |
Airship AI (AISPW) | 544.78% |
Liberty Resources Acquisition Corp Warrant (LIBYW) | 542% |
PHP Ventures Acquisition Corp Warrants (PPHPW) | 530% |
Bone Biologics Corp Warrants (BBLGW) | 510.16% |
Janux Therapeutics (JANX) | 506.55% |